Cargos activos de Karim Dabbagh
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MAAT PHARMA | Presidente | 21/06/2023 | - |
| Independent Dir/Board Member | 21/06/2023 | - |
Historial de carrera de Karim Dabbagh
Antiguos cargos conocidos de Karim Dabbagh.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Director/Miembro de la Junta | 11/09/2018 | 01/09/2023 |
| Director Ejecutivo | 11/09/2018 | 01/09/2023 | |
| Director Técnico/Científico/I+D | 01/01/2014 | 01/12/2020 | |
| Presidente | 11/09/2018 | 01/09/2023 | |
| Modus Biomedicine, Inc. | Director Ejecutivo | 01/08/2009 | 01/12/2010 |
| Fundador | 01/08/2009 | 01/12/2010 |
Formación de Karim Dabbagh.
| University College London | Doctorate Degree |
| Imperial College London | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Reino Unido | 3 |
| Francia | 2 |
Operativa
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MAAT PHARMA | Health Technology |
| Empresas privadas | 2 |
|---|---|
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Health Technology |
| Modus Biomedicine, Inc. |
- Bolsa de valores
- Insiders
- Karim Dabbagh
- Experiencia
